HC Wainwright Issues Positive Estimate for DAWN Earnings
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Equities research analysts at HC Wainwright raised their Q1 2025 earnings per share estimates for shares of Day One Biopharmaceuticals in a research note issued on Wednesday, February 26th. HC Wainwright analyst A. Maldonado now forecasts that the company will post earnings per share of ($0.28) […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Equities research analysts at HC Wainwright raised their Q1 2025 earnings per share estimates for shares of Day One Biopharmaceuticals in a research note issued on Wednesday, February 26th. HC Wainwright analyst A. Maldonado now forecasts that the company will post earnings per share of ($0.28) […]
